These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19864027)

  • 41. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
    Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
    J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human agonistic antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 induces cytotoxicity and apoptosis in prostate cancer and bladder cancer cells.
    Shimada O; Wu X; Jin X; Nouh MA; Fiscella M; Albert V; Matsuda T; Kakehi Y
    Urology; 2007 Feb; 69(2):395-401. PubMed ID: 17320696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
    Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
    BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
    Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
    Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
    Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS
    Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human framework adaptation of a mouse anti-human IL-13 antibody.
    Fransson J; Teplyakov A; Raghunathan G; Chi E; Cordier W; Dinh T; Feng Y; Giles-Komar J; Gilliland G; Lollo B; Malia TJ; Nishioka W; Obmolova G; Zhao S; Zhao Y; Swanson RV; Almagro JC
    J Mol Biol; 2010 Apr; 398(2):214-31. PubMed ID: 20226193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineering fully human monoclonal antibodies from murine variable regions.
    Bernett MJ; Karki S; Moore GL; Leung IW; Chen H; Pong E; Nguyen DH; Jacinto J; Zalevsky J; Muchhal US; Desjarlais JR; Lazar GA
    J Mol Biol; 2010 Mar; 396(5):1474-90. PubMed ID: 20045416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of bivalent and bispecific kringle single domains by loop grafting as potent agonists against death receptors 4 and 5.
    Lee CH; Park KJ; Kim SJ; Kwon O; Jeong KJ; Kim A; Kim YS
    J Mol Biol; 2011 Aug; 411(1):201-19. PubMed ID: 21664362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes.
    Sung ES; Park KJ; Lee SH; Jang YS; Park SK; Park YH; Kwag WJ; Kwon MH; Kim YS
    Mol Cancer Ther; 2009 Aug; 8(8):2276-85. PubMed ID: 19638452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression and neutralizing activity analysis of humanized single-chain antibody against anthrax protective antigen].
    Li B; Zhang J; Xu JJ; Liu SL; Fu L; Li JM; Chen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):145-8. PubMed ID: 20230675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thermodynamic consequences of mutations in vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody, 528.
    Makabe K; Nakanishi T; Tsumoto K; Tanaka Y; Kondo H; Umetsu M; Sone Y; Asano R; Kumagai I
    J Biol Chem; 2008 Jan; 283(2):1156-66. PubMed ID: 17947238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation.
    Qiao C; Hu M; Guo L; Lv M; Lin Z; Geng J; Lang X; Li X; Li Y; Ma Y; Feng J; Shen B
    BMC Immunol; 2012 Jul; 13():40. PubMed ID: 22788777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.
    Huet HA; Growney JD; Johnson JA; Li J; Bilic S; Ostrom L; Zafari M; Kowal C; Yang G; Royo A; Jensen M; Dombrecht B; Meerschaert KR; Kolkman JA; Cromie KD; Mosher R; Gao H; Schuller A; Isaacs R; Sellers WR; Ettenberg SA
    MAbs; 2014; 6(6):1560-70. PubMed ID: 25484045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo.
    Lei G; Xu M; Xu Z; Gu L; Lu C; Bai Z; Wang Y; Zhang Y; Hu H; Jiang Y; Zhao W; Tan S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells.
    Cocca BA; Seal SN; D'Agnillo P; Mueller YM; Katsikis PD; Rauch J; Weigert M; Radic MZ
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13826-31. PubMed ID: 11717440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of p38 Activation and Mitochondria in Death of Human Leukemia Cells Induced by an Agonistic Human Monoclonal Antibody Fab Specific to TRAIL Receptor 1.
    Lee YR; Hwang E; Jang YJ
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment.
    Willuda J; Honegger A; Waibel R; Schubiger PA; Stahel R; Zangemeister-Wittke U; Plückthun A
    Cancer Res; 1999 Nov; 59(22):5758-67. PubMed ID: 10582696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A chimeric antigen receptor for TRAIL-receptor 1 induces apoptosis in various types of tumor cells.
    Kobayashi E; Kishi H; Ozawa T; Hamana H; Nakagawa H; Jin A; Lin Z; Muraguchi A
    Biochem Biophys Res Commun; 2014 Oct; 453(4):798-803. PubMed ID: 25445592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.
    Seifert O; Plappert A; Heidel N; Fellermeier S; Messerschmidt SK; Richter F; Kontermann RE
    Protein Eng Des Sel; 2012 Oct; 25(10):603-12. PubMed ID: 22988132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif.
    Baek DS; Kim YS
    Biochem Biophys Res Commun; 2015 Jul; 463(3):414-20. PubMed ID: 26036575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.